Colgate-Palmolive (CL) – Research Analysts’ Weekly Ratings Updates

A number of firms have modified their ratings and price targets on shares of Colgate-Palmolive (NYSE: CL) recently:

• 2/20/2026 – Colgate-Palmolive had its “buy” rating reaffirmed by analysts at The Goldman Sachs Group, Inc.. They now have a $100.00 price target on the stock.
• 2/13/2026 – Colgate-Palmolive was given a new $93.00 price target on by analysts at Rothschild & Co Redburn.
• 2/3/2026 – Colgate-Palmolive had its price target raised by analysts at Barclays PLC from $83.00 to $88.00. They now have an “equal weight” rating on the stock.
• 2/2/2026 – Colgate-Palmolive had its “buy” rating reaffirmed by analysts at TD Cowen.
• 2/2/2026 – Colgate-Palmolive had its price target raised by analysts at Citigroup Inc. from $95.00 to $105.00. They now have a “buy” rating on the stock.
• 2/2/2026 – Colgate-Palmolive had its price target raised by analysts at Morgan Stanley from $87.00 to $100.00. They now have an “overweight” rating on the stock.
• 2/2/2026 – Colgate-Palmolive had its price target raised by analysts at Jefferies Financial Group Inc. from $85.00 to $91.00. They now have a “hold” rating on the stock.
• 2/2/2026 – Colgate-Palmolive had its price target raised by analysts at JPMorgan Chase & Co. from $93.00 to $97.00. They now have an “overweight” rating on the stock.
• 2/2/2026 – Colgate-Palmolive had its price target raised by analysts at Evercore Inc from $94.00 to $100.00. They now have an “outperform” rating on the stock.
• 2/2/2026 – Colgate-Palmolive had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $83.00 to $90.00. They now have a “hold” rating on the stock.
• 2/2/2026 – Colgate-Palmolive had its price target raised by analysts at Bank of America Corporation from $90.00 to $100.00. They now have a “buy” rating on the stock.
• 2/1/2026 – Colgate-Palmolive had its price target raised by analysts at Wells Fargo & Company from $86.00 to $94.00. They now have an “equal weight” rating on the stock.
• 1/31/2026 – Colgate-Palmolive had its “buy” rating reaffirmed by analysts at The Goldman Sachs Group, Inc.. They now have a $94.00 price target on the stock.
• 1/30/2026 – Colgate-Palmolive had its price target raised by analysts at Piper Sandler from $88.00 to $96.00. They now have an “overweight” rating on the stock.
• 1/21/2026 – Colgate-Palmolive had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings.
• 1/16/2026 – Colgate-Palmolive was given a new $83.00 price target on by analysts at Barclays PLC.
• 1/16/2026 – Colgate-Palmolive had its price target raised by analysts at JPMorgan Chase & Co. from $88.00 to $93.00. They now have an “overweight” rating on the stock.
• 1/14/2026 – Colgate-Palmolive had its price target raised by analysts at UBS Group AG from $90.00 to $93.00. They now have a “buy” rating on the stock.
• 1/13/2026 – Colgate-Palmolive was given a new $86.00 price target on by analysts at Wells Fargo & Company. They now have an “equal weight” rating on the stock.
• 1/13/2026 – Colgate-Palmolive was upgraded by analysts at Wells Fargo & Company from an “underweight” rating to an “equal weight” rating. They now have a $86.00 price target on the stock, up previously from $77.00.
• 1/8/2026 – Colgate-Palmolive had its price target lowered by analysts at TD Cowen from $90.00 to $86.00. They now have a “buy” rating on the stock.
• 1/6/2026 – Colgate-Palmolive was given a new $88.00 price target on by analysts at Piper Sandler. They now have an “overweight” rating on the stock.

Colgate-Palmolive Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st were issued a dividend of $0.52 per share. The ex-dividend date of this dividend was Wednesday, January 21st. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.2%. Colgate-Palmolive’s payout ratio is 79.39%.

Insider Transactions at Colgate-Palmolive

In related news, insider Sally Massey sold 15,851 shares of the stock in a transaction that occurred on Thursday, February 5th. The shares were sold at an average price of $95.03, for a total value of $1,506,320.53. Following the transaction, the insider owned 13,751 shares in the company, valued at approximately $1,306,757.53. This represents a 53.55% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Panagiotis Tsourapas sold 35,000 shares of Colgate-Palmolive stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $94.61, for a total transaction of $3,311,350.00. Following the sale, the chief operating officer owned 10,415 shares of the company’s stock, valued at approximately $985,363.15. The trade was a 77.07% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 184,683 shares of company stock valued at $17,486,693 in the last quarter. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.